About Waterley Pharma

Committed to help people feel healthier and live a longer life.

ABOUT US

Headquartered in Hyderabad – India, Waterley Pharmaceuticals is led by a team of dynamic professionals with rich experience acquired through their work at the world’s leading healthcare companies.

With millions of people in dire need of new medical solutions, Waterley Pharmaceuticals aims to help as many people as possible, with special focus on the gastro-intestinal therapy area. Providing innovative and effective formulations that are easily accessible to all patients is our goal.

OVERVIEW

Gastrointestinal diseases in Asian populations have been a major health issue during the past two decades. The incidence and prevalence rates have shown a notable rise, with the consequence that GI diseases are increasingly the cause of morbidity and mortality in Asian countries.

In the present scenario, while diseases like diarrhoeas, hepatitis, typhoid, TB of the intestinal tract etc. are still prevalent, there is an alarming is the rise of lifestyle diseases like Irritable Bowel syndrome (IBS), Gastroesophageal reflux disease (GERD), inflammatory bowel disease like Crohn’s and non-alcoholic fatty liver and cancers of the food pipe, colon and liver, pancreas and gallbladder.

Waterley Pharmaceuticals sees opportunities in this growing gastrointestinal therapy segment in India and neighbouring Asian countries. The company markets innovative, high quality medications to meet the evolving challenges and unmet needs of patients.

MILESTONES

2014

Incorporation of Waterley Pharmaceuticals.

2016

Market Expansion in North Eastern States, India.

2017

Expanded operations in South India.

2018

Launch of Hepsure.

2015

The launch of Waterley Pharmaceuticals.
Evir & Hepkart

2017

Launch of Mycolon range & Cretox CP.

2017

Market Expansion in Western India.

2014

Incorporation of Waterley Pharmaceuticals.

2015

The launch of Waterley Pharmaceuticals. Evir & Hepkart

2016

Market Expansion in North Eastern States, India.

2017

Launch of Mycolon range & Cretox CP.

2017

Expanded operations in South India.

2017

Market Expansion in Western India.

2018

Launch of Hepsure.

MANAGEMENT

MANISH SUTRAVE

DIRECTOR

Manish Sutrave is the Director of the company since its incorporation in 2014.  A first generation entrepreneur and one of the founders of Waterley, Manish drives the organizations market expansion and sales initiatives.

R.S. VENUGOPAL REDDY

DIRECTOR

Venugopal Reddy is a Director in Waterley since its inception in 2014. Venu has extensive experience in the pharmaceutical specialty business for more than two decades. He drives the branding initiatives of the company’s products and also is responsible for financial operations. Venugopal Reddy is a Post Graduate in Management Studies.

B. MEGAM REDDY

DIRECTOR

Megam Reddy is a Director since its inception in 2014. He has over a decade of experience in specialty pharmaceuticals with work experience in multinational and Indian companies. Megam is a Post Graduate in Bioinformatics from Köln University, Germany.

K.P. SHINOD

DIRECTOR

K.P. Shinod is a Director in the company since 2014.  His responsibilities include corporate affairs and he has an impeccable understanding of business and finance. Shinod is a Post Graduate in Commerce from Calicut University, Kerala and a Fellow member of The Institute of Company Secretaries of India, New Delhi. He is a practicing Company Secretary since 2008.